Nova Patents
IS6750A

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Abstract

Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

Term

Term ended

Projected expiry passed 18 March 2023, 3.5 years ago.

  1. Priority
  2. Filed
  3. Projected expiry
  4. Today

178 members in 41 offices

This recordMember, by publication datePriority claim31 more offices are in the list below

Priority claims13

Priority claims
DocumentOfficeKindDate
23351900United States of AmericaP
23351900United States of AmericaP
28443801United States of AmericaP
28443801United States of AmericaP
28473001United States of AmericaP
28473001United States of AmericaP
0119655United States of AmericaW
0119655United States of AmericaW
PCTUS0119655–––
US20000233519P–––
US20010284438P–––
US20010284730P–––
WO2001US19655–––

Members178

Family members, oldest first
DocumentOfficeKind
CA2413417A1CanadaA1
CA2413596A1CanadaA1
CA2413683A1CanadaA1
WO0200617A2World Intellectual Property Organization (WIPO)A2
WO0200653A2World Intellectual Property Organization (WIPO)A2
WO0200716A2World Intellectual Property Organization (WIPO)A2
AU1560902AAustraliaA
AU6700801AAustraliaA
AU8821301AAustraliaA
UY26808A1UruguayA1
UY26809A1UruguayA1
CA2423071A1CanadaA1
WO0224702A1World Intellectual Property Organization (WIPO)A1
AU6994301AAustraliaA
US2002058290A1United States of AmericaA1
WO0200716A3World Intellectual Property Organization (WIPO)A3
WO0200653A3World Intellectual Property Organization (WIPO)A3
PE20020729A1PeruA1
US2002173445A1United States of AmericaA1
NO20026167D0NorwayD0
NO20026167LNorwayL
NO20026194D0NorwayD0
WO0200617A3World Intellectual Property Organization (WIPO)A3
KR20030014407ARepublic of KoreaA
KR20030016310ARepublic of KoreaA
NO20026194LNorwayL
IS6750AThis recordIcelandA
NO20031266D0NorwayD0
PE20030186A1PeruA1
ECSP024410AEcuadorA
EP1297108A2European Patent Office (EPO)A2
EP1299094A2European Patent Office (EPO)A2
EP1299385A2European Patent Office (EPO)A2
KR20030028847ARepublic of KoreaA
CZ20024214A3CzechiaA3
NO20031266LNorwayL
MXPA02012563AMexicoA
MXPA02012573AMexicoA
MXPA02012605AMexicoA
IL152491D0IsraelD0
EP1319007A1European Patent Office (EPO)A1
US2003114420A1United States of AmericaA1
BR0113980ABrazilA
IL152719D0IsraelD0
IL152890D0IsraelD0
WO03053354A2World Intellectual Property Organization (WIPO)A2
AU2002359727A1AustraliaA1
AU2002359727A8AustraliaA8
CA2471342A1CanadaA1
UY27595A1UruguayA1
WO03062241A1World Intellectual Property Organization (WIPO)A1
CN1443187AChinaA
BR0111869ABrazilA
AR031709A1ArgentinaA1
CZ20024250A3CzechiaA3
TW200304810ATaiwan Province of ChinaA
IL155019D0IsraelD0
CN1454083AChinaA
HK1054230A1Hong Kong, ChinaA1
WO03053354A3World Intellectual Property Organization (WIPO)A3
HU0303165A2HungaryA2
HU0303172A2HungaryA2
BG107675ABulgariaA
CZ2003780A3CzechiaA3
ZA200209530BSouth AfricaB
ZA200210313BSouth AfricaB
JP2004509072AJapanA
JP2004509895AJapanA
US2004077605A1United States of AmericaA1
US2004077606A1United States of AmericaA1
SK4982003A3SlovakiaA3
MXPA03002412AMexicoA
AR035340A1ArgentinaA1
JP2004515462AJapanA
RU2003102390ARussian FederationA
JP2004517606AJapanA
IS7324AIcelandA
HU0400455A2HungaryA2
ZA200302963BSouth AfricaB
RU2003101918ARussian FederationA
NO20043068LNorwayL
US2004176324A1United States of AmericaA1
EP1458723A1European Patent Office (EPO)A1
NZ524803ANew ZealandA
PL361707A1PolandA1
EP1463728A2European Patent Office (EPO)A2
KR20040086248ARepublic of KoreaA
BR0215281ABrazilA
WO03062241A8World Intellectual Property Organization (WIPO)A8
TR200202702T2TürkiyeT2
AR037950A1ArgentinaA1
PL366565A1PolandA1
EE200300108AEstoniaA
CN1589271AChinaA
HU0402554A2HungaryA2
AU2001288213B2AustraliaB2
CN1608069AChinaA
HU0402672A2HungaryA2
HRP20030305A2CroatiaA2
BR0111298ABrazilA
Showing 100 of 178